Declining diagnostic accuracy of non-invasive fibrosis tests is associated with elevated alanine aminotransferase in chronic hepatitis B

doi:10.12998/wjcc.v6.i12.521

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7015)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

335

WORD

193

HTML

3616

Figures (1-3)

183

Tables (1-4)

192

Sum=4519

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

993

Download

1503

Sum=2496

Oct 26, 2018 (publication date) through May 18, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Oct 26, 2018; 6(12): 521-530
Published online Oct 26, 2018. doi: 10.12998/wjcc.v6.i12.521

Table 1 Baseline characteristics of the subjects

Characteristics	Total group(n = 599)	ALT ≤ 40 group (n = 272)	40 < ALT ≤ 80group (n = 190)	ALT > 80 group(n = 137)	P-value
Age (yr)	37 (29, 44)	39 (31.25, 46)	37.5 (28, 43.25)	34 (28, 40.5)	< 0.001
Male (%)	349 (58.3)	131 (48.2)	130 (68.4)	88 (64.2)	< 0.001
ALT (U/L)	44 (28, 76)	26 (31, 33)	56 (48, 66)	127 (95, 218.5)	< 0.001
AST (U/L)	32 (24, 48)	24 (20, 28)	36 (31, 42)	70 (55, 115.5)	< 0.001
GGT (U/L)	25 (17, 41)	19 (14, 25)	30 (20, 41.25)	48 (30, 78)	< 0.001
Cholesterol (mmol/L)	4.31 (3.84, 4.96)	4.35 (3.86, 4.95)	4.24 (3.75, 4.95)	4.34 (3.84, 4.99)	0.732
PLT (10⁹/L)	182 (150, 217)	184 (155, 223)	177.5 (145.5, 212)	180 (149, 215)	0.215
INR	1 (1, 1.1)	1 (1, 1.1)	1 (0.99, 1.1)	1 (0.94, 1.1)	0.4
HBV DNA (log₁₀IU/mL)	7.03 (4.24, 8.23)	4.77 (3.32, 7.78)	7.64 (5.72, 8.23)	8.03 (6.81, 8.23)	< 0.001
S (%)
S0	264 (44.1)	128 (47.1)	80 (42.1)	56 (40.9)
S1	147 (24.5)	73 (26.8)	53 (27.9)	21 (15.3)
S2	96 (16)	35 (12.9)	29 (15.3)	32 (23.4)
S3	54 (9)	19 (7.0)	18 (9.5)	17 (12.4)
S4	38 (6.3)	17 (6.3)	10 (5.3)	11 (8.0)
Stage S0-1 fibrosis	411 (68.6)	201 (73.9)	133 (70)	77 (56.2)	0.001
Stage S2-4 fibrosis	188 (31.4)	71 (26.1)	57 (30)	60 (43.8)
APRI	0.53 (0.38,0.86)	0.38 (0.3, 0.49)	0.61 (0.44,0.8)	1.16 (0.88, 1.93)	< 0.001
FIB-4	1.02 (0.72,1.47)	1.02 (0.72,1.37)	0.96 (0.66,1.55)	1.22 (0.82, 1.79)	< 0.001
GPR	0.22 (0.15,0.38)	0.16 (0.11, 0.23)	0.24 (0.17,0.38)	0.42 (0.25, 0.68)	< 0.001
King’s score	6.77 (4.31,11.49)	4.89 (3.54,7.03)	7.18 (4.58,11.58)	13.04 (9.81, 27.15)	< 0.001
Forns index	6.48 (5.44,7.51)	6.33 (5.37,7.37)	6.57 (5.51,7.69)	6.65 (5.57, 7.57)	0.081

Data are expressed as the n (%) or median (interquartile range, IQR). ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; GGT: Gamma-glutamyl transferase; PLT: Platelet; S: Stage of fibrosis; GPR: Gamma-glutamyl transpeptidase (GGT)-to-platelet ratio; APRI: Aspartate aminotransferase (AST)-to-platelet (PLT) ratio index; FIB-4: Fibrosis index based on 4 factors; INR: International sensitivity index.

Citation: Wang L, Fan YX, Dou XG. Declining diagnostic accuracy of non-invasive fibrosis tests is associated with elevated alanine aminotransferase in chronic hepatitis B. World J Clin Cases 2018; 6(12): 521-530
URL: https://www.wjgnet.com/2307-8960/full/v6/i12/521.htm
DOI: https://dx.doi.org/10.12998/wjcc.v6.i12.521